Remdesivir for the treatment of COVID‐19

Background Remdesivir is an antiviral medicine with properties to inhibit viral replication of SARS‐CoV‐2. Positive results from early studies attracted media attention and led to emergency use authorisation of remdesivir in COVID‐19. A thorough understanding of the current evidence regarding the e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2021-08, Vol.2021 (8), p.CD014962
Hauptverfasser:	Grundeis, Felicitas, Ansems, Kelly, Dahms, Karolina, Mikolajewska, Agata, Thieme, Volker, Piechotta, Vanessa, Metzendorf, Maria-Inti, Stegemann, Miriam, Benstoem, Carina, Fichtner, Falk
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Monophosphate Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - therapeutic use Alanine Alanine - analogs & derivatives Alanine - therapeutic use Antiviral Agents Antiviral Agents - therapeutic use Bias Cause of Death Confidence Intervals COVID-19 COVID-19 - mortality COVID-19 Drug Treatment Disease Progression Humans Infectious disease Medicine General & Introductory Medical Sciences Middle Aged Oxygen Oxygen - administration & dosage Randomized Controlled Trials as Topic Respiration, Artificial SARS-CoV-2 Ventilator Weaning
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!